24 HOUR WU ALLOCATION
| Research | Percent |
|---|---|
|
ATGPA1 POST TRANSLATIONAL MODIFICATIONS |
83.53% |
|
ENZYME DYNAMICS |
15.29% |
|
ATSTP10 SUCROSE TRANSPORT |
1.18% |
7 DAY WU ALLOCATION
| Research | Percent |
|---|---|
|
ATGPA1 POST TRANSLATIONAL MODIFICATIONS |
66.29% |
|
CANCER |
16.12% |
|
ENZYME DYNAMICS |
11.56% |
|
ATGPA1 POST TRANSLATIONAL MODIFICATION DYNAMICS |
4.23% |
|
MEMBRANE TRANSPORT |
1.63% |
|
ATSTP10 SUCROSE TRANSPORT |
.16% |
12 WEEK WU ALLOCATION
| Research | Percent |
|---|---|
|
ALZHEIMERS |
47.71% |
|
ATGPA1 POST TRANSLATIONAL MODIFICATIONS |
20.84% |
|
ENZYME DYNAMICS |
8.65% |
|
CANCER |
7.15% |
|
INFLUENZA |
3.9% |
|
RCA OLIGOMER STABILITY SIMULATIONS |
3.87% |
|
RCA STABILITY SIMULATIONS |
1.94% |
|
ATGPA1 POST TRANSLATIONAL MODIFICATION DYNAMICS |
1.39% |
|
MEMBRANE TRANSPORT |
1.17% |
|
RCA THERMAL STABILITY SIMULATIONS |
.76% |
|
RCA TEMPERATURE STABILITY SIMULATIONS |
.76% |
|
NIPAH VIRUS DECOY PROTEIN DYNAMICS |
.62% |
|
RCA OLIGOMERIC STABILITY SIMULATIONS |
.55% |
|
RCA OLIGOMERIC STABILITY TEMPERATURE SIMULATIONS |
.5% |
|
NIPAH VIRUS DECOY PROTEINS |
.17% |
|
ATSTP10 SUCROSE TRANSPORT |
.02% |